10.1016/j.fertnstert.2020.04.002 [DOI] [PubMed] [Google Scholar] Ma L., Li X., Li C., Chen P., Lan Y., Huang Y., et al
She found Zepbound 1 through social media, researched it with the same attention she brings to her client projects, and started tracking everything from week 1: weight, waist-hip measurements, weekly photos, energy levels, mood ratings
But they dont occur in a majority of patients and they often dissipate with ongoing use
In a discussion about the physician survey, the President of Omada Health, Wei-Li Shao, told Fierce Healthcare that, We believe that the decision to start, stop, or continue a GLP-1 should be made in the medical home between the patient and their primary care physician. The concept of the medical home has been defined by the American Academy of Pediatrics as, An approach to providing comprehensive and high quality primary care.that is accessible, family-centered, continuous, comprehensive, coordinated, compassionate, and culturally effective. AAP also notes that a medical home, is not a building or place, extending beyond the walls of a clinical practice
23rd December 2024, A/Prof Chee L Khoo Is this one of those adverse events related to the GLP1 agonist your patient saw on google one day
doi:10.1016/s0165-0173(97)00045-3
